NEK4 and neoplasm: Utilizing biomimetic carriers such as leukosomes for microRNA-based gene therapy could provide a platform to modulate NEK4 or its downstream pathways, especially as these preferentially hone to areas of inflammation, such as what may be found in a tumor.